ELIN KARLSSON • Department of Medical Biochemistry and Microbiology, BMC, Uppsala
University, Uppsala, Sweden
STEFAN H. KNAUER • Biopolymers, University of Bayreuth, Bayreuth, Germany
SIMONE KUNZELMANN • Structural Biology Science Technology Platform, The Francis Crick
Institute, London, UK
DAVID M. LAWSON • Department of Biological Chemistry, John Innes Centre, Norwich
Science Park, Norwich, UK
XIAOCHUN LI-BLATTER • Biophysics Facility, Biozentrum, University of Basel,
Basel, Switzerland
STEPHEN R. MARTIN • Structural Biology Science Technology Platform, The Francis Crick
Institute, London, UK
LAURA MASINO • Structural Biology Science Technology Platform, The Francis Crick
Institute, London, UK
BENOIT MEYER • Institut de Biologie Mole ´culaire et Cellulaire, CNRS, Universite ´ de
Strasbourg, Strasbourg, France
DAVID MURRAY • Hit Discovery, Discovery Sciences, R&D BioPharmaceuticals, AstraZeneca,
Alderley Park, UK
ADEWALE OLAMOYESAN • Department of Molecular Sciences, Macquarie University, Sydney,
NSW, Australia
LORI A. PASSMORE • MRC Laboratory of Molecular Biology, Cambridge, UK
HELEN PLANT • Hit Discovery, Discovery Sciences, R&D BioPharmaceuticals, AstraZeneca,
Alderley Park, UK
ANDRES RAMOS • Department of Structural & Molecular Biology, University College London,
London, UK
BERTRAND RAYNAL • Plate-forme de Biophysique Mole ´culaire, Institut Pasteur, UMR 3528
CNRS, Paris, France
ALISON RODGER • Department of Molecular Sciences, Macquarie University, Sydney,
NSW, Australia
TAIICHI SAKAMOTO • Institut de Biologie Mole ´culaire et Cellulaire, CNRS, Universite ´ de
Strasbourg, Strasbourg, France; Department of Life Science, Faculty of Advanced
Engineering, Chiba Institute of Technology, Chiba, Japan
EMMA SCHENCKBECHER • Institut de Biologie Mole ´culaire et Cellulaire, CNRS, Universite ´ de
Strasbourg, Strasbourg, France
MARIA J. SCHILSTRA • Structural Biology Technology Platform, The Francis Crick Institute,
London, UK
MAXIMILIAN SEIDEL • MRC Laboratory of Molecular Biology, Cambridge, UK
HANNAH SEMPLE • Hit Discovery, Discovery Sciences, R&D BioPharmaceuticals,
AstraZeneca, Alderley Park, UK
TIMOTHY SHARPE • Biophysics Facility, Biozentrum, University of Basel, Basel, Switzerland
JOSEPH SHAW • Discovery Biology, Discovery Sciences, IMED Biotech Unit, AstraZeneca,
Cambridge, UK
IAN SINCLAIR • Hit Discovery, Discovery Sciences, R&D BioPharmaceuticals, AstraZeneca,
Alderley Park, UK
JORDAN T. B. STARIHA • Department of Biochemistry and Microbiology, University of
Victoria, Victoria, BC, Canada
CLARE E. M. STEVENSON • Department of Biological Chemistry, John Innes Centre, Norwich
Research Park, Norwich, UK
JAMES A. W. STOWELL • MRC Laboratory of Molecular Biology, Cambridge, UK
x
Contributors
University, Uppsala, Sweden
STEFAN H. KNAUER • Biopolymers, University of Bayreuth, Bayreuth, Germany
SIMONE KUNZELMANN • Structural Biology Science Technology Platform, The Francis Crick
Institute, London, UK
DAVID M. LAWSON • Department of Biological Chemistry, John Innes Centre, Norwich
Science Park, Norwich, UK
XIAOCHUN LI-BLATTER • Biophysics Facility, Biozentrum, University of Basel,
Basel, Switzerland
STEPHEN R. MARTIN • Structural Biology Science Technology Platform, The Francis Crick
Institute, London, UK
LAURA MASINO • Structural Biology Science Technology Platform, The Francis Crick
Institute, London, UK
BENOIT MEYER • Institut de Biologie Mole ´culaire et Cellulaire, CNRS, Universite ´ de
Strasbourg, Strasbourg, France
DAVID MURRAY • Hit Discovery, Discovery Sciences, R&D BioPharmaceuticals, AstraZeneca,
Alderley Park, UK
ADEWALE OLAMOYESAN • Department of Molecular Sciences, Macquarie University, Sydney,
NSW, Australia
LORI A. PASSMORE • MRC Laboratory of Molecular Biology, Cambridge, UK
HELEN PLANT • Hit Discovery, Discovery Sciences, R&D BioPharmaceuticals, AstraZeneca,
Alderley Park, UK
ANDRES RAMOS • Department of Structural & Molecular Biology, University College London,
London, UK
BERTRAND RAYNAL • Plate-forme de Biophysique Mole ´culaire, Institut Pasteur, UMR 3528
CNRS, Paris, France
ALISON RODGER • Department of Molecular Sciences, Macquarie University, Sydney,
NSW, Australia
TAIICHI SAKAMOTO • Institut de Biologie Mole ´culaire et Cellulaire, CNRS, Universite ´ de
Strasbourg, Strasbourg, France; Department of Life Science, Faculty of Advanced
Engineering, Chiba Institute of Technology, Chiba, Japan
EMMA SCHENCKBECHER • Institut de Biologie Mole ´culaire et Cellulaire, CNRS, Universite ´ de
Strasbourg, Strasbourg, France
MARIA J. SCHILSTRA • Structural Biology Technology Platform, The Francis Crick Institute,
London, UK
MAXIMILIAN SEIDEL • MRC Laboratory of Molecular Biology, Cambridge, UK
HANNAH SEMPLE • Hit Discovery, Discovery Sciences, R&D BioPharmaceuticals,
AstraZeneca, Alderley Park, UK
TIMOTHY SHARPE • Biophysics Facility, Biozentrum, University of Basel, Basel, Switzerland
JOSEPH SHAW • Discovery Biology, Discovery Sciences, IMED Biotech Unit, AstraZeneca,
Cambridge, UK
IAN SINCLAIR • Hit Discovery, Discovery Sciences, R&D BioPharmaceuticals, AstraZeneca,
Alderley Park, UK
JORDAN T. B. STARIHA • Department of Biochemistry and Microbiology, University of
Victoria, Victoria, BC, Canada
CLARE E. M. STEVENSON • Department of Biological Chemistry, John Innes Centre, Norwich
Research Park, Norwich, UK
JAMES A. W. STOWELL • MRC Laboratory of Molecular Biology, Cambridge, UK
x
Contributors
